Teligent Change in Accounts Receivable 2010-2021 | TLGT
Teligent change in accounts receivable from 2010 to 2021. Change in accounts receivable can be defined as the increase or decrease in accounts receivable for the given period.
Teligent Annual Change in Accounts Receivable
(Millions of US $) |
| 2020 |
$9 |
| 2019 |
$-4 |
| 2018 |
$-4 |
| 2017 |
$6 |
| 2016 |
$-8 |
| 2015 |
$1 |
| 2014 |
$-9 |
| 2013 |
$-3 |
| 2012 |
$0 |
| 2011 |
$0 |
| 2010 |
$0 |
| 2009 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
|
